Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Goodwill & Intangibles (2016 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Goodwill & Intangibles for 10 consecutive years, with $6.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Goodwill & Intangibles changed 0.0% year-over-year to $6.7 million, compared with a TTM value of $6.7 million through Sep 2025, changed 0.0%, and an annual FY2024 reading of $6.7 million, down 24.13% over the prior year.
  • Goodwill & Intangibles was $6.7 million for Q3 2025 at Kiora Pharmaceuticals, roughly flat from $6.7 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $13.4 million in Q1 2021 and bottomed at $6.7 million in Q3 2024.
  • Average Goodwill & Intangibles over 5 years is $9.4 million, with a median of $9.9 million recorded in 2021.
  • The sharpest move saw Goodwill & Intangibles surged 145.58% in 2021, then dropped 24.13% in 2024.
  • Year by year, Goodwill & Intangibles stood at $10.8 million in 2021, then fell by 0.17% to $10.7 million in 2022, then dropped by 18.01% to $8.8 million in 2023, then dropped by 24.13% to $6.7 million in 2024, then changed by 0.0% to $6.7 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for KPRX at $6.7 million in Q3 2025, $6.7 million in Q2 2025, and $6.7 million in Q1 2025.